By inhibiting GLI-1 and GLI-3 in HCC cells, bufalin downregulates downstream target molecules (MMP-2, MMP-9, β-catenin, and VEGF) and upregulates E-cadherin expression, affecting GLI-3 expression. The gene discussed is MMP9; the disease is hepatocellular carcinoma.